Amalgamated Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,512
| Closed | -$441K | – | 2998 |
|
|
2023
Q4 | $441K | Buy |
7,512
+699
| +10% | +$39.3K | ﹤0.01% | 1489 |
|
|
2023
Q3 | $297K | Sell |
6,813
-18
| -0.3% | -$643 | ﹤0.01% | 1634 |
|
|
2023
Q2 | $247K | Sell |
6,831
-301
| -4% | -$12.4K | ﹤0.01% | 1741 |
|
|
2023
Q1 | $265K | Sell |
7,132
-1,069
| -13% | -$48.1K | ﹤0.01% | 1694 |
|
|
2022
Q4 | $372K | Buy |
8,201
+369
| +5% | +$23.9K | ﹤0.01% | 1599 |
|
|
2022
Q3 | $547K | Buy |
7,832
+78
| +1% | +$5.77K | 0.01% | 1384 |
|
|
2022
Q2 | $521K | Sell |
7,754
-1,538
| -17% | -$97.8K | ﹤0.01% | 1443 |
|
|
2022
Q1 | $764K | Buy |
9,292
+742
| +9% | +$75.9K | 0.01% | 1339 |
|
|
2021
Q4 | $1.25M | Buy |
8,550
+1,439
| +20% | +$223K | 0.01% | 1140 |
|
|
2021
Q3 | $1.26M | Sell |
7,111
-422
| -6% | -$67.9K | 0.01% | 1134 |
|
|
2021
Q2 | $1.22M | Buy |
7,533
+1,442
| +24% | +$232K | 0.01% | 1188 |
|
|
2021
Q1 | $1.04M | Sell |
6,091
-587
| -9% | -$116K | 0.04% | 535 |
|
|
2020
Q4 | $1.47M | Buy |
6,678
+843
| +14% | +$182K | 0.06% | 356 |
|
|
2020
Q3 | $969K | Sell |
5,835
-48
| -0.8% | -$6.57K | 0.04% | 465 |
|
|
2020
Q2 | $672K | Buy |
5,883
+782
| +15% | +$75.8K | 0.03% | 651 |
|
|
2020
Q1 | $392K | Buy |
5,101
+206
| +4% | +$18.5K | 0.01% | 1019 |
|
|
2019
Q4 | $631K | Buy |
4,895
+473
| +11% | +$45.6K | 0.01% | 1000 |
|
|
2019
Q3 | $345K | Sell |
4,422
-60
| -1% | -$5.63K | 0.01% | 1233 |
|
|
2019
Q2 | $462K | Buy |
4,482
+1,245
| +38% | +$96.9K | 0.01% | 1111 |
|
|
2019
Q1 | $237K | Buy |
+3,237
| New | +$220K | 0.01% | 1413 |
|
Other funds holding MRTX
Amalgamated Bank's MRTX Position: Q1 2024 in Review
Amalgamated Bank sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 7,512 shares — an estimated $441K sold.
Amalgamated Bank first reported a position in MRTX in Q1 2019 and held it in 20 quarters. The position peaked at $1.47M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Amalgamated Bank reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Amalgamated Bank sold 7,512 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $441K.
- Amalgamated Bank first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
- Amalgamated Bank's Mirati Therapeutics, Inc. Common Stock position peaked at $1.47M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Amalgamated Bank's 13F filing for Q1 2024, filed 23 Apr 2024.